E. Bodar

发表

Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.

J. Meer, J. Drenth, A. Simon, 2005, The Netherlands journal of medicine.

Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement

O. Hoekstra, C. Leemans, J. Castelijns, 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.

Effects of the Histone Deacetylase Inhibitor ITF2357 in Autoinflammatory Syndromes

J. Meer, A. Simon, E. Bodar, 2011, Molecular medicine.

Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra).

M. de Visser, A. Simon, E. Bodar, 2009, The Netherlands journal of medicine.

Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment.

J. V. D. van der Meer, H. D. de Koning, A. Simon, 2007, Seminars in arthritis and rheumatism.

On-demand anakinra treatment is effective in mevalonate kinase deficiency

J. van der Meer, A. Simon, J. Drenth, 2011, Annals of the rheumatic diseases.

Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1β by mononuclear cells through a caspase 1-mediated process

M. Netea, B. Kullberg, J. V. D. van der Meer, 2008, Annals of the rheumatic diseases.

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome.

J. Drenth, J. V. D. van der Meer, W. V. van Heerde, 2007, Blood.

Follow-up, clinical features, and quality of life in 10.3 patients with HyperImmunoglubulin D syndrome

J. Meer, J. Drenth, A. Simon, 2008 .

Beneficial response to interleukin 1 receptor antagonist in traps.

J. Drenth, J. V. D. van der Meer, J. V. D. van der Hilst, 2004, The American journal of medicine.

Lovastatin inhibits formation of AA amyloid

J. Meer, B. Kluve-Beckerman, A. Simon, 2008, Journal of leukocyte biology.

Variable expression and treatment of PAPA syndrome

E. Hoppenreijs, J. V. D. van der Meer, A. Simon, 2011, Annals of the rheumatic diseases.

Immunologic and biologic properties of the primary tumor during prolonged neoadjuvant chemoimmunotherapy.

T. D. de Gruijl, E. van der Wall, J. Buter, 2002, Oncology.

Beneficial response to anakinra and thalidomide in Schnitzler’s syndrome

M. Netea, J. V. D. van der Meer, H. D. de Koning, 2005, Annals of the rheumatic diseases.

Dysregulation of innate immunity: hereditary periodic fever syndromes

J. Drenth, J. V. D. van der Meer, A. Simon, 2009, British journal of haematology.

Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome

J. Drenth, J. V. D. van der Meer, A. Simon, 2008, Medicine.

Schnitzler's syndrome Beneficial response to anakinra and thalidomide in

J. Meer, A. Simon, E. Bodar, 2005 .

Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome

J. Meer, A. Simon, J. Bijzet, 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

On-demand anakinra treatment is effective in mevalonate kinase deficiency

J. Drenth, J. Frenkel, E. Bodar, 2011, Annals of the rheumatic diseases.